4 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
Follow Taizhou HoudeAoke Biomedical Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of LP002 for the Treatment of Patients With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma LP002 - Primary Mediastinal Large B-Cell Lymphoma (PMBCL) | Phase 2 | Unknown | Taizhou HoudeAoke Biomedical Co., Ltd. | 69 | 2020-12-30 | 2020-10-23 |
| Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer LP002, Carboplatin, Etoposide - Small-cell Lung Cancer | Phase 2 | Unknown | Taizhou HoudeAoke Biomedical Co., Ltd. | 46 | 2020-12-02 | 2021-02-05 |
| A Study of HX008 Plus LP002 for the Treatment of Patients With Advanced Melanoma HX008, LP002 - Melanoma | Phase 1 | Unknown | Taizhou HoudeAoke Biomedical Co., Ltd. | 63 | 2020-08-20 | 2021-02-16 |
| A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms LP002, Cisplatin, Fluorouracil - Digestive System Neoplasms | Phase 1 | Unknown | Taizhou HoudeAoke Biomedical Co., Ltd. | 94 | 2019-06-17 | 2021-02-16 |
Digestive System Neoplasms (1) · Melanoma (1) · Small Cell Lung Carcinoma (1)
Carboplatin (1) · Cisplatin (1) · Etoposide (1) · Fluorouracil (1)
China (4)
Yuankai Shi, MD (1)